Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aleksandra Avramovska"'
Autor:
Emilie Sapart, Tatiana Sokolova, Stéphanie de Montjoye, Stéphanie Dierckx, Adrien Nzeusseu, Aleksandra Avramovska, Laurent Meric de Bellefon, Patrick Durez
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 4, Pp 875-886 (2023)
Abstract Introduction This study sought to analyze the benefit of an early induction therapy with a biological disease-modifying anti-rheumatic drugs (bDMARD) during the first year of treatment with a 5-year follow-up in early rheumatoid arthritis (E
Externí odkaz:
https://doaj.org/article/5f3cde5297754110a4abce9a2f8071a5
Autor:
Stéphanie Dierckx, Tatiana Sokolova, Bernard R. Lauwerys, Aleksandra Avramovska, Laurent Meric de Bellefon, Adrien Nzeusseu Toukap, Maria Stoenoiu, Frédéric A. Houssiau, Patrick Durez
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-7 (2020)
Abstract Background/purpose Studies have demonstrated that rheumatoid arthritis (RA) patients who achieve low disease activity or remission are able to taper biological disease-modifying antirheumatic drugs (bDMARDs). The aim of this study was to eva
Externí odkaz:
https://doaj.org/article/8af3ef776b9d4758bbb641d31824b1d7
Autor:
Xavier Theunssens, Laura Bricman, Stéphanie Dierckx, Emilie Sapart, Tatiana Sokolova, Aleksandra Avramovska, Patrick Durez
Publikováno v:
Rheumatology and therapy, Vol. 9, no. 2, p. 763-770 (2022)
Drug-induced sarcoidosis-like disease is a rare side effect of anti-tumor necrosis factor (anti-TNF) agents in rheumatoid arthritis (RA) patients. The most commonly involved organs in such condition are the lungs, skin, and lymph nodes. The aim of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::926ea6646ae503db3dc5011fbd28af09
https://hdl.handle.net/2078.1/258462
https://hdl.handle.net/2078.1/258462